|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.412 EUR | -1.10% |
|
+6.49% | -27.71% |
| 06-24 | Valneva's Chikungunya Vaccine Receives Health Canada's Approval | MT |
| 06-24 | Valneva rises after Canadian approval for its chikungunya vaccine | RE |
May 31 (Reuters) - The European Medicines Agency (EMA) recommended the use of Valneva's single-shot vaccine for chikungunya virus, the regulator said on Friday. (Reporting by Christy Santhosh in Bengaluru; Editing by Ravi Prakash Kumar)
| 1st Jan change | Capi. | |
|---|---|---|
| -27.71% | 508M | |
| +38.36% | 52.73B | |
| +36.73% | 39B | |
| -8.63% | 38.52B | |
| +25.46% | 30.38B | |
| -11.17% | 26.39B | |
| +11.44% | 26.08B | |
| +45.09% | 14.15B | |
| +32.93% | 12.6B | |
| -5.30% | 11.51B |
VALNEVA 
